Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Inflammation 1 Hematologic Diseases 1 Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 20 Brentuximab Vedotin 20 fludarabine 16 Lenalidomide 13 Rituximab 12 Dexamethasone 12 fludarabine phosphate 10 Melphalan 10 Busulfan 10 Mycophenolic Acid 9 dacetuzumab 7 Whole-Body Irradiation 7 Tacrolimus 7 pirtobrutinib 6 Doxorubicin 6 Bortezomib 6 Azacitidine 6 ruxolitinib 5 Vincristine 5 Prednisone 5 Imatinib Mesylate 5 ponatinib 4 pomalidomide 4 Mesna 4 Granulocyte Colony-Stimulating Factor 4 Etoposide 4 Bone Marrow Transplantation 4 Bendamustine Hydrochloride 4 venetoclax 3 nilotinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hematologic Diseases × CHR 2845 × Clear all

NCT00820508 2011-11-28

CHR-2845-001

Chroma Therapeutics

Phase 1 Completed

Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡